 | • レポートコード：MRC23Q36033 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のゲノム＆プロテオミクスツール市場について調査・分析し、世界のゲノム＆プロテオミクスツール市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ゲノミクス、プロテオミクス）、用途別セグメント分析（研究所＆研究所、創薬、バイオインフォマティクス、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、3billion, Inc.、Bio-Rad Laboratories, Inc.、Lucigen Corp.、Macrogen, Inc.、Abbott、Thermal Fisher Scientific, Inc.、Bio-Synthesis, Inc.、GE Healthcare、QIAGEN NV、Novogene Corp.、Waters Corp.、OriGene Technologies、Takara Bio, Inc.、Vela Diagnosticsなどが含まれています。 世界のゲノム＆プロテオミクスツール市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ゲノム＆プロテオミクスツール市場規模を推定する際に考慮しました。本レポートは、ゲノム＆プロテオミクスツールの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ゲノム＆プロテオミクスツールに関するビジネス上の意思決定に役立てることを目的としています。 ・ゲノム＆プロテオミクスツール市場の概要 - ゲノム＆プロテオミクスツールのタイプ別セグメント - 世界のゲノム＆プロテオミクスツール市場規模：タイプ別分析（ゲノミクス、プロテオミクス） - ゲノム＆プロテオミクスツールの用途別セグメント - 世界のゲノム＆プロテオミクスツール市場規模：用途別分析（研究所＆研究所、創薬、バイオインフォマティクス、その他） - 世界のゲノム＆プロテオミクスツール市場規模予測（2018年-2029年） ・ゲノム＆プロテオミクスツール市場の成長トレンド - ゲノム＆プロテオミクスツールの地域別市場規模（2018年-2029年） - ゲノム＆プロテオミクスツール市場ダイナミクス - ゲノム＆プロテオミクスツールの業界動向 - ゲノム＆プロテオミクスツール市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ゲノミクス、プロテオミクス - 世界のゲノム＆プロテオミクスツールのタイプ別市場規模（2018年-2023年） - 世界のゲノム＆プロテオミクスツールのタイプ別市場規模（2024年-2029年） ・用途別セグメント：研究所＆研究所、創薬、バイオインフォマティクス、その他 - 世界のゲノム＆プロテオミクスツールの用途別市場規模（2018年-2023年） - 世界のゲノム＆プロテオミクスツールの用途別市場規模（2024年-2029年） ・ゲノム＆プロテオミクスツールの地域別市場規模 - 北米のゲノム＆プロテオミクスツール市場規模（2018年-2029年） - アメリカのゲノム＆プロテオミクスツール市場規模（2018年-2029年） - ヨーロッパのゲノム＆プロテオミクスツール市場規模（2018年-2029年） - アジア太平洋のゲノム＆プロテオミクスツール市場規模（2018年-2029年） - 中国のゲノム＆プロテオミクスツール市場規模（2018年-2029年） - 日本のゲノム＆プロテオミクスツール市場規模（2018年-2029年） - 韓国のゲノム＆プロテオミクスツール市場規模（2018年-2029年） - インドのゲノム＆プロテオミクスツール市場規模（2018年-2029年） - オーストラリアのゲノム＆プロテオミクスツール市場規模（2018年-2029年） - 中南米のゲノム＆プロテオミクスツール市場規模（2018年-2029年） - 中東・アフリカのゲノム＆プロテオミクスツール市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 3billion, Inc.、Bio-Rad Laboratories, Inc.、Lucigen Corp.、Macrogen, Inc.、Abbott、Thermal Fisher Scientific, Inc.、Bio-Synthesis, Inc.、GE Healthcare、QIAGEN NV、Novogene Corp.、Waters Corp.、OriGene Technologies、Takara Bio, Inc.、Vela Diagnostics ・アナリストの観点/結論 ・調査方法とデータソース |
Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
Highlights
The global Genomic and Proteomic Tool market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Genomic and Proteomic Tool is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genomic and Proteomic Tool is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Genomic and Proteomic Tool in Research Labs and Institutes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Genomic and Proteomic Tool include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare and QIAGEN NV, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic and Proteomic Tool.
The Genomic and Proteomic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genomic and Proteomic Tool market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic and Proteomic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics
Segment by Type
Genomics
Proteomics
Segment by Application
Research Labs and Institutes
Drug Discovery
Bioinformatics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic and Proteomic Tool companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic and Proteomic Tool Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genomics
1.2.3 Proteomics
1.3 Market by Application
1.3.1 Global Genomic and Proteomic Tool Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Research Labs and Institutes
1.3.3 Drug Discovery
1.3.4 Bioinformatics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic and Proteomic Tool Market Perspective (2018-2029)
2.2 Genomic and Proteomic Tool Growth Trends by Region
2.2.1 Global Genomic and Proteomic Tool Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomic and Proteomic Tool Historic Market Size by Region (2018-2023)
2.2.3 Genomic and Proteomic Tool Forecasted Market Size by Region (2024-2029)
2.3 Genomic and Proteomic Tool Market Dynamics
2.3.1 Genomic and Proteomic Tool Industry Trends
2.3.2 Genomic and Proteomic Tool Market Drivers
2.3.3 Genomic and Proteomic Tool Market Challenges
2.3.4 Genomic and Proteomic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic and Proteomic Tool Players by Revenue
3.1.1 Global Top Genomic and Proteomic Tool Players by Revenue (2018-2023)
3.1.2 Global Genomic and Proteomic Tool Revenue Market Share by Players (2018-2023)
3.2 Global Genomic and Proteomic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomic and Proteomic Tool Revenue
3.4 Global Genomic and Proteomic Tool Market Concentration Ratio
3.4.1 Global Genomic and Proteomic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic and Proteomic Tool Revenue in 2022
3.5 Genomic and Proteomic Tool Key Players Head office and Area Served
3.6 Key Players Genomic and Proteomic Tool Product Solution and Service
3.7 Date of Enter into Genomic and Proteomic Tool Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic and Proteomic Tool Breakdown Data by Type
4.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2018-2023)
4.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2024-2029)
5 Genomic and Proteomic Tool Breakdown Data by Application
5.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2018-2023)
5.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genomic and Proteomic Tool Market Size (2018-2029)
6.2 North America Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genomic and Proteomic Tool Market Size by Country (2018-2023)
6.4 North America Genomic and Proteomic Tool Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic and Proteomic Tool Market Size (2018-2029)
7.2 Europe Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genomic and Proteomic Tool Market Size by Country (2018-2023)
7.4 Europe Genomic and Proteomic Tool Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic and Proteomic Tool Market Size (2018-2029)
8.2 Asia-Pacific Genomic and Proteomic Tool Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2018-2023)
8.4 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic and Proteomic Tool Market Size (2018-2029)
9.2 Latin America Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genomic and Proteomic Tool Market Size by Country (2018-2023)
9.4 Latin America Genomic and Proteomic Tool Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic and Proteomic Tool Market Size (2018-2029)
10.2 Middle East & Africa Genomic and Proteomic Tool Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2018-2023)
10.4 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3billion, Inc.
11.1.1 3billion, Inc. Company Detail
11.1.2 3billion, Inc. Business Overview
11.1.3 3billion, Inc. Genomic and Proteomic Tool Introduction
11.1.4 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.1.5 3billion, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Detail
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Lucigen Corp.
11.3.1 Lucigen Corp. Company Detail
11.3.2 Lucigen Corp. Business Overview
11.3.3 Lucigen Corp. Genomic and Proteomic Tool Introduction
11.3.4 Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.3.5 Lucigen Corp. Recent Development
11.4 Macrogen, Inc.
11.4.1 Macrogen, Inc. Company Detail
11.4.2 Macrogen, Inc. Business Overview
11.4.3 Macrogen, Inc. Genomic and Proteomic Tool Introduction
11.4.4 Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.4.5 Macrogen, Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Genomic and Proteomic Tool Introduction
11.5.4 Abbott Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.5.5 Abbott Recent Development
11.6 Thermal Fisher Scientific, Inc.
11.6.1 Thermal Fisher Scientific, Inc. Company Detail
11.6.2 Thermal Fisher Scientific, Inc. Business Overview
11.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Introduction
11.6.4 Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.6.5 Thermal Fisher Scientific, Inc. Recent Development
11.7 Bio-Synthesis, Inc.
11.7.1 Bio-Synthesis, Inc. Company Detail
11.7.2 Bio-Synthesis, Inc. Business Overview
11.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Introduction
11.7.4 Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.7.5 Bio-Synthesis, Inc. Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Genomic and Proteomic Tool Introduction
11.8.4 GE Healthcare Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.8.5 GE Healthcare Recent Development
11.9 QIAGEN NV
11.9.1 QIAGEN NV Company Detail
11.9.2 QIAGEN NV Business Overview
11.9.3 QIAGEN NV Genomic and Proteomic Tool Introduction
11.9.4 QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.9.5 QIAGEN NV Recent Development
11.10 Novogene Corp.
11.10.1 Novogene Corp. Company Detail
11.10.2 Novogene Corp. Business Overview
11.10.3 Novogene Corp. Genomic and Proteomic Tool Introduction
11.10.4 Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.10.5 Novogene Corp. Recent Development
11.11 Waters Corp.
11.11.1 Waters Corp. Company Detail
11.11.2 Waters Corp. Business Overview
11.11.3 Waters Corp. Genomic and Proteomic Tool Introduction
11.11.4 Waters Corp. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.11.5 Waters Corp. Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Detail
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies Genomic and Proteomic Tool Introduction
11.12.4 OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.12.5 OriGene Technologies Recent Development
11.13 Takara Bio, Inc.
11.13.1 Takara Bio, Inc. Company Detail
11.13.2 Takara Bio, Inc. Business Overview
11.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Introduction
11.13.4 Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.13.5 Takara Bio, Inc. Recent Development
11.14 Vela Diagnostics
11.14.1 Vela Diagnostics Company Detail
11.14.2 Vela Diagnostics Business Overview
11.14.3 Vela Diagnostics Genomic and Proteomic Tool Introduction
11.14.4 Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2018-2023)
11.14.5 Vela Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details